文献速递瓣膜外科

标准化乳头肌复位治疗IIIb型继发性二尖瓣反流改善2年结局

Standardized papillary muscle relocation for type IIIb secondary mitral regurgitation improves 2-year outcome.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

本研究比较二尖瓣成形术联合乳头肌复位与单纯成形术治疗IIIb型继发性二尖瓣反流的2年结局。共105例患者,联合组51例,单纯组54例。联合组主要复合终点(死亡或二尖瓣反流≥2复发)为19.6%(10/51),显著优于单纯组的44.4%(24/54;P=0.009)。

要点

  • 联合乳头肌复位组2年主要复合终点19.6%(10/51),显著优于单纯成形组44.4%(24/54;P=0.009)。
  • 2年全因死亡率联合组7.8%(4/51) vs 单纯组18.5%(10/54),P=0.098,未达统计学显著。
  • 联合组2年后纽约心脏协会功能分级较基线显著改善。

核心结论

  • 在IIIb型继发性二尖瓣反流患者中,二尖瓣成形术联合乳头肌复位较单纯成形术改善了2年结局。
  • 针对二尖瓣叶拴系的乳头肌复位是射血分数降低的心力衰竭合并IIIb型继发性二尖瓣反流患者的有效治疗选择。

研究设计与样本

  • 连续纳入105例术前左心室射血分数<45%、左心室舒张末期内径>55 mm且拴系高度>10 mm的IIIb型继发性二尖瓣反流患者,均完成二尖瓣修复术后2年随访。
  • 联合组51例接受二尖瓣成形术联合乳头肌复位(研究组),对照组54例接受单纯二尖瓣成形术。
  • 主要复合终点为术后2年死亡或二尖瓣反流≥2复发。

主要发现

  • 反映左心室功能障碍严重程度及二尖瓣叶拴系的超声心动图基线变量两组相似。
  • 手术及围手术期结局两组相当。
  • 主要复合终点联合组19.6%(10/51) vs 单纯组44.4%(24/54),P=0.009,联合组显著改善。
  • 2年全因死亡率联合组7.8%(4/51) vs 单纯组18.5%(10/54),P=0.098,未达统计学显著。
  • 联合组2年后纽约心脏协会功能分级较基线值显著改善。

关键数值与推荐

  • 纳入标准:IIIb型继发性二尖瓣反流,术前左心室射血分数<45%,左心室舒张末期内径>55 mm,拴系高度>10 mm。
  • 主要复合终点联合组19.6%(10/51) vs 单纯组44.4%(24/54),P=0.009。
  • 2年全因死亡率联合组7.8%(4/51) vs 单纯组18.5%(10/54),P=0.098。

临床怎么用

  • 作者认为,针对二尖瓣叶拴系的乳头肌复位是射血分数降低的心力衰竭合并IIIb型继发性二尖瓣反流患者的有效治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The major drawback of isolated annuloplasty for treatment of secondary mitral regurgitation (SMR) with restricted leaflet motion during systole (type IIIb) is the recurrence of SMR, leading to adverse clinical outcome. Additional papillary muscle relocation (PMR) specifically addresses leaflet tethering to restore mitral valve geometry. We aimed to compare the 2-year outcome of annuloplasty with additional PMR vs isolated annuloplasty. METHODS: A total of 105 consecutive type IIIb SMR patients with preoperative left ventricular (LV) ejection faction <45%, left ventricular end-diastolic diameter >55 mm and a tenting height >10 mm reached 2-year postoperative follow-up after mitral valve repair and were included in the current analysis. A total of 51 patients underwent annuloplasty and additional PMR (study group). A total of 54 patients underwent isolated annuloplasty (control group). Primary composite study end point comprised death or recurrence of mitral regurgitation ≥2 at 2 years postoperatively. RESULTS: Echocardiographic baseline variables indicating the severity of LV dysfunction and mitral leaflet tethering were similar. Procedural and periprocedural outcome was comparable in both groups. The primary composite end point was significantly improved in the study group (19.6% [10/51]) in comparison to the control group (44.4% [24/54]; P = 0.009). Two-year all-cause mortality was 7.8% [4/51] in the study group vs 18.5% [10/54] in the control group (P = 0.098). After 2 years, a significant improvement in New York Heart Association functional class as compared to the baseline values was observed in the study group. CONCLUSIONS: Additional PMR to treat SMR type IIIb resulted in an improved 2-year outcome in comparison to isolated annuloplasty. PMR specifically addressing mitral leaflet tethering represents a valid therapeutic option for heart failure patients with SMR type IIIb.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Pausch J, Sequeira Gross TM, Bhadra OD, et al. Standardized papillary muscle relocation for type IIIb secondary mitral regurgitation improves 2-year outcome. Eur J Cardiothorac Surg. 2022. PMID: 35511127. doi:10.1093/ejcts/ezac285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。